Estrella Immunopharma, Inc. ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune ...
OutSystems, a leading AI development platform, today announced that it has achieved Federal Risk and Authorization Management Program (FedRAMP) Authorization. With this certification, OutSystems now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results